Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
continous glucose monitor
Biolinq raises $100M for intradermal glucose sensor for type 2 diabetes
By
Jessica Hagen
|
12:26 pm |
April 22, 2025
The company's patch uses intradermal electrochemical sensors to monitor glucose levels and provide metabolic insights to individuals with type 2 diabetes not on insulin.
